UBS Group’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $416K | Sell |
|
|||||
|
2025
Q1 | $1.06M | Buy |
|
|||||
|
2024
Q4 | $1.36M | Buy |
|
|||||
|
2024
Q3 | $65.5K | Buy |
|
|||||
|
2024
Q2 | $37.2K | Buy |
|
|||||
|
2024
Q1 | $16 | Sell |
|
|||||
|
2023
Q4 | $17.5K | Buy |
|
|||||
|
2023
Q3 | $9 | Hold |
|
|||||
|
2023
Q2 | $13 | Hold |
|
|||||
|
2023
Q1 | $14 | Sell |
|
|||||
|
2022
Q4 | $1.42K | Sell |
|
|||||
|
2022
Q3 | $13K | Buy |
|
|||||
|
2022
Q2 | $12K | Buy |
|
|||||
|
2022
Q1 | $10K | Sell |
|
|||||
|
2021
Q4 | $34K | Buy |
|
|||||
|
2021
Q3 | $33K | Buy |
|